publication . Article . 2007

Simultaneous Onset of Ulcerative Colitis and Disseminated Pyoderma Gangrenosum

Neesse, Albrecht; Michl, Patrick; Kunsch, Steffen; Ellenrieder, Volker; Gress, Thomas M.; Steinkamp, Martin;
Open Access English
  • Published: 01 Oct 2007 Journal: Case Reports in Gastroenterology, volume 1, issue 1, pages 110-115 (issn: 1662-0631, eissn: 1662-0631, Copyright policy)
  • Publisher: Karger Publishers
Abstract
Pyoderma gangrenosum (PG) is an immune-mediated inflammatory skin condition representing one of the most distinct extraintestinal manifestations of inflammatory bowel disease (IBD). PG occurs independently from intestinal disease activity in about 1–2% of patients suffering from ulcerative colitis or Crohn's disease and is characterized by chronic deep skin ulcers whose exact pathogenesis is still unknown. So far, patients with ulcerative colitis have only been reported to develop PG during the course of IBD but not at the initial manifestation of bowel symptoms. This is the first report demonstrating the simultaneous onset of ulcerative colitis and severe multi...
Subjects
mesheuropmc: digestive system diseases
free text keywords: Disseminated pyoderma gangrenosum, Diseases of the digestive system. Gastroenterology, Published: October 2007, RC799-869, Infliximab, Ulcerative colitis

Callen, JP. Pyoderma gangrenosum. Lancet. 1998; 351: 581-585 [PubMed]

Nguyen, KH, Miller, JJ, Helm, KF. Case reports and a review of the literature on ulcers mimicking pyoderma gangrenosum. Int J Dermatol. 2003; 42: 84-94 [PubMed]

Ross, HJ, Moy, LA, Kaplan, R, Figlin, RA. Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment. Cancer. 1991; 68: 441-443 [PubMed]

Montoto, S, Bosch, F, Estrach, T, Blade, J, Nomdedeu, B, Nontserrat, E. Pyoderma gangrenosum triggered by alpha2b-interferon in a patient with chronic granulocytic leukemia. Leuk Lymphoma. 1998; 30: 199-202 [PubMed]

Srebrnik, A, Shachar, E, Brenner, S. Suspected induction of a pyoderma gangrenosum-like eruption due to sulpiride treatment. Cutis. 2001; 67: 253-256 [PubMed]

Langholz, E. Ulcerative colitis: An epidemiological study based on a regional inception cohort, with special reference to disease course and prognosis. Dan Med Bull. 1999; 46: 400-415 [PubMed]

Reichrath, J, Bens, G, Bonowitz, A, Tilgen, W. Treatment recommendations for pyoderma gangrenosum: An evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol. 2005; 53: 273-283 [PubMed]

Brooklyn, TN, Dunnill, MG, Shetty, A, Bowden, JJ, Williams, JD, Griffiths, CE, Forbes, A, Greenwood, R, Probert, CS. Infliximab for the treatment of pyoderma gangrenosum: A randomised, double blind, placebo controlled trial. Gut. 2006; 55: 505-509 [OpenAIRE] [PubMed]

Regueiro, M, Valentine, J, Plevy, S, Fleisher, MR, Lichtenstein, GR. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol. 2003; 98: 1821-1826 [PubMed]

Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Article . 2007

Simultaneous Onset of Ulcerative Colitis and Disseminated Pyoderma Gangrenosum

Neesse, Albrecht; Michl, Patrick; Kunsch, Steffen; Ellenrieder, Volker; Gress, Thomas M.; Steinkamp, Martin;